Medicine Grand Rounds: Advancing Cell Therapy for Patients with Blood Cancers

Stefanie Sarantopoulos, MD, PhD, Professor of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University Department of Medicine will present "Advancing Cell Therapy for Patients with Blood Cancers" Learning Objectives: -Explain the benefits and risks of allogeneic hematopoietic stem cell transplantation (HCT) in patients with blood disorders and cancers -Diagnostic and treatment criteria for chronic graft versus host disease -Pathophysiology of chronic graft versus host disease and the implications for other diseases -How we can harness what we've learned about HCT to produce safe and efficacious adoptive T cell therapies for cancer